Detailed information for compound 571716

Basic information

Technical information
  • TDR Targets ID: 571716
  • Name: (3S)-3-amino-3-ureido-propanoic acid
  • MW: 147.133 | Formula: C4H9N3O3
  • H donors: 4 H acceptors: 3 LogP: -4.59 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: OC(=O)C[C@H](NC(=O)N)N
  • InChi: 1S/C4H9N3O3/c5-2(1-3(8)9)7-4(6)10/h2H,1,5H2,(H,8,9)(H3,6,7,10)/t2-/m0/s1
  • InChiKey: LYKIYOKXXWRCHS-REOHCLBHSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (3S)-3-amino-3-ureidopropanoic acid
  • (3S)-3-(aminocarbonylamino)-3-azanyl-propanoic acid
  • (3S)-3-amino-3-ureido-propionic acid
  • (3S)-3-amino-3-(carbamoylamino)propanoic acid
  • albizziin
  • (3S)-3-amino-3-(aminocarbonylamino)propanoic acid
  • 585-23-9
  • 70190-84-0
  • 3-((Aminocarbonyl)amino)alanine
  • Alanine, 3-((aminocarbonyl)amino)-
  • EINECS 209-550-8
  • 2-Amino-3-ureidopropionic acid

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni hypothetical protein 0.001 0.9804 0.9804
Leishmania major hypothetical protein, conserved 0.001 1 1
Giardia lamblia Nuclear LIM interactor-interacting factor 1 0.001 1 0.5
Echinococcus granulosus Carboxy terminal domain RNA polymerase II 0.001 1 1
Trichomonas vaginalis nuclear lim interactor-interacting factor, putative 0.001 1 0.5
Schistosoma mansoni polyadenylate binding protein 0.0007 0.5764 0.5764
Toxoplasma gondii Dullard family phosphatase domain-containing protein 0.001 1 1
Schistosoma mansoni nuclear lim interactor-interacting factor (nli-interacting factor) (nli-if) 0.001 1 1
Plasmodium falciparum NLI interacting factor-like phosphatase, putative 0.001 1 1
Plasmodium vivax NLI interacting factor-like phosphatase, putative 0.001 1 1
Loa Loa (eye worm) hypothetical protein 0.001 0.9804 0.9804
Schistosoma mansoni polyadenylate binding protein 0.0007 0.5764 0.5764
Trichomonas vaginalis nuclear lim interactor-interacting factor, putative 0.001 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0007 0.5764 0.5764
Trichomonas vaginalis dullard protein, putative 0.001 1 0.5
Plasmodium vivax NLI interacting factor-like phosphatase, putative 0.001 1 1
Echinococcus multilocularis 0.001 1 1
Echinococcus multilocularis Carboxy terminal domain RNA polymerase II 0.001 1 1
Trichomonas vaginalis nuclear lim interactor-interacting factor, putative 0.001 1 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.001 1 1
Schistosoma mansoni nuclear lim interactor-interacting factor (nli-interacting factor) (nli-if) 0.001 1 1
Trichomonas vaginalis dullard protein, putative 0.001 1 0.5
Trichomonas vaginalis dullard protein, putative 0.001 1 0.5
Echinococcus granulosus CTD small phosphatase protein like 0.001 1 1
Schistosoma mansoni polyadenylate binding protein 0.0007 0.5764 0.5764
Loa Loa (eye worm) hypothetical protein 0.001 1 1
Trichomonas vaginalis nuclear lim interactor-interacting factor, putative 0.001 1 0.5
Trypanosoma brucei Mitochondrial import inner membrane translocase subunit TIM50 0.001 1 1
Entamoeba histolytica NLI interacting factor-like phosphatase domain-containing protein 0.001 1 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.